Sinopharm sets price range for $1.13 billion IPO

The Chinese distributor of pharmaceutical products will be the first company to take orders for a Hong Kong listing after the summer and has set the price range at HK12.25 to HK$16 per share.

Sinopharm, the largest distributor of pharmaceutical products in China, will be the first company to start accepting orders for a Hong Kong initial public offering when it kicks off its roadshow today. It is getting a head start on the five companies that are currently engaged in investor education and several others that are expected to follow in the weeks ahead.

The state-owned company will seek to raise between HK$6.68 billion and HK$8.73 billion $862 million to $1.13...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: ipo | healthcare | pharmaceuticals | sinopharm | cicc | morgan stanley | ubs

Print Edition

FinanceAsia Print Edition